Cabergoline 0.25 - ZPHC

As a dopamine agonist, Cabergoline’s mechanism of action revolves around its ability to bind selectively to dopamine D2 receptors, effectively inhibiting prolactin production. This specificity makes it an ideal choice for treating hyperprolactinemia with minimal risk of affecting other hormones, including luteinizing hormone or thyroid-stimulating hormone. Due to its ergot-derived structure, Cabergoline has a unique profile that avoids many of the systemic side effects seen in other prolactin inhibitors. It is commonly used for hormone regulation, particularly when high prolactin levels lead to fertility or gynecomastia issues​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Cabergoline 0.25 by ZPHC, consult with your doctor or healthcare professional.